Progress in the treatment of Neurofibromatosis type 2
10.3760/cma.j.cn431274-20200722-01020
- VernacularTitle:神经纤维瘤病2型的治疗进展
- Author:
Bingqian YANG
1
;
Qingquan HUA
;
Huidong CHEN
;
Jie REN
;
Yang JIANG
Author Information
1. 武汉大学人民医院耳鼻喉一科 430060
- From:
Journal of Chinese Physician
2020;22(8):1121-1125
- CountryChina
- Language:Chinese
-
Abstract:
Neurofibromatosis type 2 is an autosomal dominant inherited disease with a low incidence. It often involves the central and peripheral nervous systems, leading to bilateral hearing loss, balance difficulties, facial paralysis and other symptoms, which seriously affects the quality of life of patients. Therefore, in the treatment of neurofibromatosis type 2, preservation of facial nerve function is crucial. The diagnosis and treatment scheme should take into account the characteristics of the tumor and the patient′s wishes. Individualized programmes of multidisciplinary collaboration are needed.
